Surgery on neuroendocrine tumours

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 21, Issue 1, 2007, Pages 87-109

  Åkerström, Göran ^b   Hellman, Per ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

gastrointestinal; liver metastases; neuroendocrine tumours; pancreatic; surgical treatment

Indexed keywords

ALPHA INTERFERON; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CHROMOGRANIN A; DIAZOXIDE; GASTRIN; GLUCAGON; GLUCOSE; INSULIN; OCTREOTIDE; ORAL ANTIDIABETIC AGENT; PENTETREOTIDE; SOMATOSTATIN DERIVATIVE; SULFONYLUREA;

APPENDECTOMY; APPENDIX TUMOR; ARTIFICIAL EMBOLISM; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOID; CARCINOID SYNDROME; CHOLECYSTECTOMY; COLON RESECTION; COLON TUMOR; CYTOREDUCTIVE SURGERY; GASTRECTOMY; GASTRIN BLOOD LEVEL; GASTRINOMA; GASTROINTESTINAL TUMOR; GASTROSCOPY; GLUCAGON BLOOD LEVEL; GLUCAGONOMA; GLUCOSE BLOOD LEVEL; HEMICOLECTOMY; HUMAN; HYPERGASTRINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULINOMA; LAPAROSCOPIC SURGERY; LIVER LOBECTOMY; LIVER METASTASIS; LUNG EMBOLISM; LYMPH NODE METASTASIS; MESENTERY TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PERNICIOUS ANEMIA; PROGNOSIS; RADIOFREQUENCY ABLATION; RECTUM TUMOR; REVIEW; STOMACH ACID SECRETION; STOMACH CARCINOID; SURGICAL TECHNIQUE; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME; VIPOMA; ZOLLINGER ELLISON SYNDROME;

ALGORITHMS; CARCINOID TUMOR; GASTRINOMA; GLUCAGONOMA; HUMANS; INSULINOMA; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NESIDIOBLASTOSIS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS; VIPOMA; ZOLLINGER-ELLISON SYNDROME;

EID: 33947282871     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2006.12.004     Document Type: Review

References (55)

1. Åkerström G., Hellman P., and Hessman O. Gastrointestinal carcinoids. In: Lennard T.W.J. (Ed). Endocrine Surgery (2006), Elsevier 163-198
2. Modlin I.M., Lye K.D., and Kidd M. A 5-decade analysis of 13,715 carcinoid tumours. Cancer 97 (2003) 934-959
3. Modlin I.M., Kidd M., Latich I., et al. Current status of gastrointestinal carcinoids. Gastroenterology 128 (2005) 1717-1751
4. Delle Fave G., Capurso G., Milione M., and Panzuto F. Endocrine tumours of the stomach. Best Practice & Research. Clinical Gastroenterology 19 (2005) 659-673
5. Ichikawa J., Tanabe S., Koizumi W., et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 35 (2003) 203-206
6. Ahlman H., Kölby L., Lundell L., et al. Clinical management of gastric carcinoid tumors. Digestion 55 supplement 3 (1994) 77-85
7. Bordi C., Corleto V.D., Azzoni C., et al. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 2236-2242
8. Bordi C., Falchetti A., Azzoni C., et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. The American Journal of Surgical Pathology 21 (1997) 1075-1082
9. Richards M.L., Gauger P., Thompson N.W., and Giordano T.J. Regression of type II gastric carcinoid in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World Journal of Surgery 28 (2004) 652-658
10. Norton J.A., Melcher M.L., Gibril F., and Jensen R.T. Gastric carcinoids tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery 136 (2004) 1267-1274
11. Shinohara T., Ohyama S., Nagano H., et al. Minute gastric carcinoid tumor with regional lymph node metastasis. Gastric Cancer 6 (2003) 262-266
12. Wilander E., El-Salhy M., and Pitkänen P. Histopathology of gastric carcinoids: a survey of 42 cases. Histopathology 8 (1984) 183-193
13. Rindi G., Bordi C., Rappel S., et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behavior. World Journal of Surgery 20 (1996) 168-172
14. Rindi G., Azzoni C., La Rosa S., et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116 (1999) 532-542
15. Öhrvall U., Eriksson B., Juhlin C., et al. Method of dissection of mesenteric metastases in mid-gut carcinoid tumors. World Journal of Surgery 24 (2000) 1402-1408
16. Makridis C., Öberg K., Juhlin C., et al. Surgical treatment of mid-gut carcinoids tumors. World Journal of Surgery 14 (1990) 377-385
17. Makridis C., Ekbom A., Bring J., et al. Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors. Surgery 122 (1997) 1075-1082
18. Makridis C., Rastad J., Öberg K., and Åkerström G. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World Journal of Surgery 20 (1996) 900-907
19. Hellman P., Lundström T., Öhrvall U., et al. Effect of surgery on the outcome of midgut carcinoids disease with lymph node and liver metastases. World Journal of Surgery 26 (2002) 991-997
20. Goede A.C., Caplin M.E., and Winslet M.C. Carcinoid tumor of the appendix. The British Journal of Surgery 90 (2003) 1317-1322
21. Stinner B., and Rothmund M. Neuroendocrine tumours (carcinoids) of the appendix. Best Practice & Research. Clinical Gastroenterology 19 (2005) 729-738
22. Ballantyne G.H., Savoca P.E., Flannery J.T., et al. Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer 69 (1992) 2400-2405
23. Vogelsang H., and Siewert J.R. Endocrine tumours of the hindgut. Best Practice & Research. Clinical Gastroenterology 19 (2005) 739-752
24. Koura A.N., Giacco G.G., Curley S.A., et al. Carcinoid tumors of the rectum: effect of size, histopathology and surgical treatment on metastasis free survival. Cancer 79 (1997) 1294-1298
25. Suzuki H., and Ikeda K. Endoscopic mucosal resection and full thickness resection with complete defect closure for early gastrointestinal malignancies. Endoscopy 33 (2001) 437-439
26. Nakagoe T., Ishikawa H., Sawai T., et al. Gasless video endoscopic transanal excision of rectal tumors incompletely removed by colonoscopic snare polypectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A 13 (2003) 99-103
27. Åkerström G., Hellman P., Hessman O., and Osmak L. Surgical treatment of endocrine pancreatic tumours. Neuroendocrinology 80 supplement 1 (2004) 62-66
28. Scarlett J.A., Mako M.E., Rubenstein A.H., et al. Factitious hypoglycemia: diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. The New England Journal of Medicine 297 (1977) 1029-1032
29. Thompson N.W., Dzako P.F., Fritts L.L., et al. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery 116 (1994) 1131-1138
30. Anderson M.A., Carpenter S., Thompson N.W., et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. The American Journal of Gastroenterology 95 (2000) 2271-2277
31. Doppman J.L., Chang R., Fraker D.L., et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Annals of Internal Medicine 123 (1995) 269
32. Grant C.S. Insulinoma. Best Practice & Research Clinical Gastroenterology 19 (2005) 783-798
33. Service G.J., Thompson G.B., Service F.J., et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. The New England Journal of Medicine 353 (2005) 249-254
34. Imamura M., and Takahashi K. Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome. World Journal of Surgery 17 (1993) 433-438
35. Norton J.A., Fraker D.L., and Alexander H.R. Surgery to cure the Zollinger-Ellison syndrome. The New England Journal of Medicine 341 (1999) 635-644
36. Yu F., Venzon D.J., Serrano J., et al. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison Syndrome. Journal of Clinical Oncology 17 (1999) 615-630
37. Doherty G.M. Rare endocrine tumours of the GI tract. Best Practice & Research. Clinical Gastroenterology 19 (2005) 807-818
38. Hellman P., Andersson M., Rastad J., et al. Surgical strategy for large or malignant endocrine pancreatic tumours. World Journal of Surgery 24 (2000) 1353-1360
39. Kouvaraki M.A., Solorzano C.C., Shapiro S.E., et al. Surgical treatment of non-functioning pancreatic islet cell tumors. Journal of Surgical Oncology 89 (2005) 170-185
40. Öberg K., and Eriksson B. Endocrine tumours of the pancreas. Best Practice & Research. Clinical Gastroenterology 19 (2005) 753-782
41. Bartsch D.K., Schilling T., Ramaswamy A., et al. Management of nonfunctioning isle cell carcinomas. World Journal of Surgery 24 (2000) 1418-1424
42. Åkerström G., Hessman O., Hellman P., and Skogseid B. Pancreatic tumours as part of the MEN-1 syndrome. Best Practice & Research. Clinical Gastroenterology 19 (2005) 819-830
43. Dean P.G., van Heerden J.A., Farley D.R., et al. Are patients with multiple endocrine neoplasia type 1 prone to premature death?. World Journal of Surgery 1 (2000) 1437-1441
44. Doherty G.M., Olson J.A., Frisella M.M., et al. Lethality of multiple endocrine neoplasia type 1. World Journal of Surgery 22 (1998) 581-587
45. Åkerström G., Hessman O., and Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumours of the pancreas in MEN 1. Langenbeck's Archives of Surgery 386 (2002) 558-569
46. Skogseid B., Rastad J., and Åkerström G. Pancreatic endocrine tumors in multiple endocrine neooplasia type 1. In: Doherty G., and Skogseid B. (Eds). Surgical Endocrinology (2001), Williams & Wilkins, Philadelphia, Lippincott 511-525
47. Gauger P.G., Scheiman J.M., Wamsteker E.-M., et al. Role of endoscopic ultrasound in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. The British Journal of Surgery 90 (2003) 748-754
48. Hellman P., Hennings J., Åkerström G., and Skogseid B. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1. The British Journal of Surgery 92 (2005) 1508-1512
49. Doherty G.M. Multiple endocrine neoplasia type 1: duodenopancreatic tumors. Surgical Oncology 12 (2003) 135-143
50. McEntee G.P., Nagorney D.M., Kvols C.K., et al. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 108 (1990) 1091-1096
51. Wängberg B., Westberg G., Tylén U., et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World Journal of Surgery 20 (1996) 892-899
52. Nave H., Mössinger E., Feist H., et al. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 129 (2001) 170-175
53. Hellman P., Ladjevardi S., Skogseid B., et al. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World Journal of Surgery 26 (2002) 1052-1056
54. Elias D., Lasser P., Ducreux M., et al. Liver resection (and associated extrahepatic resections) for metastatic well-diferentiated endocrine tumors: a 15-year single center prospective study. Surgery 133 (2003) 375-382
55. Norton J.A., Warren R.S., Kelly M.F., et al. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 134 (2003) 1057-1065